title: Photo(chemo)therapy for vitiligo.
abstract: Vitiligo is a common skin disease characterized by loss of normal melanin pigments in the skin and its pathogenesis is still unclear. Treatment modalities include psoralen plus ultraviolet A, narrow-band ultraviolet B (NB UVB) phototherapy, topical and systemic steroids, topical calcineurin inhibitors, topical vitamin D analogues in monotherapy or in association with phototherapy, and surgical treatment. NB UVB (310-315 nm) radiation is now considered as the 'gold standard' for the treatment of diffuse vitiligo, and treatment with two recently introduced UVB sources that emit 308 nm wavelengths, the 308 nm xenon chloride (XeCl) excimer laser and the 308 nm XeCl excimer light, has also been reported to be effective and might be the treatment of choice for localized disease: this treatment modality has been defined as 'targeted phototherapy.'
authors.affiliation: Photodermatology Unit, San Gallicano Dermatological Institute, Roma, Italy.
authors.forename: Alessia
authors.initials: A
authors.lastname: Pacifico
authors.forename: Giovanni
authors.initials: G
authors.lastname: Leone
mesh_terms: D005363:Ficusin / Q000627:therapeutic use*; D006801:Humans; D011701:PUVA Therapy / Q000295:instrumentation* / Q000379:methods*; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D014466:Ultraviolet Rays; D014820:Vitiligo / Q000188:drug therapy*
chemical_list: D017319:Photosensitizing Agents; D005363:Ficusin